Social Factors for Prostate Cancer

Enrolling by invitation at 1 trial location
Age: 18+
Sex: Male
Trial Phase: Academic
Sponsor: Mayo Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how social factors influence the health decisions of immigrant men from Sub-Saharan Africa and the Caribbean, focusing on prostate cancer care and survivorship. It aims to understand the differences and similarities in health-seeking behaviors among men from various African regions. Participants will engage in surveys and interviews to share their experiences. Men who have prostate cancer, immigrated from Sub-Saharan Africa or the Caribbean, and speak English may be suitable for this study.

As an unphased study, this research provides participants the opportunity to contribute to a deeper understanding of cultural influences on health decisions, potentially improving care for their communities.

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores how social determinants impact prostate cancer care and survivorship among Sub-Saharan African and Caribbean immigrant men. Unlike traditional treatments that focus solely on the biological aspects of prostate cancer, this approach seeks to understand and address the social and cultural factors that influence patient outcomes. By gathering insights through surveys and interviews, the trial aims to uncover barriers to care and improve support systems, potentially leading to more personalized and effective interventions for these communities.

Who Is on the Research Team?

GB

Gladys B. Asiedu, Ph.D.

Principal Investigator

Mayo Clinic in Rochester

Are You a Good Fit for This Trial?

Inclusion Criteria

I am a man from Africa diagnosed with prostate cancer.
I can sign a consent form and participate in an interview.
I can speak and understand English.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

AIM I

Participants complete a survey and participate in an interview in person, over the phone, or via zoom

Baseline
1 visit (in-person, phone, or zoom)

AIM II

Participants complete an interview in person, over the phone, or via zoom

Baseline
1 visit (in-person, phone, or zoom)

Follow-up

Participants are monitored for any additional insights or data collection needs post-interview

4 weeks

What Are the Treatments Tested in This Trial?

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: ObservationalExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Mayo Clinic

Lead Sponsor

Trials
3,427
Recruited
3,221,000+

Congressionally Directed Medical Research Programs

Collaborator

Trials
59
Recruited
10,600+